Insight journal - Company

Gilead Partnering: Scientific breakthrough a product of collaboration

Posted on 16 July 2013

Tags: , , ,

Gilead Sciences is a top biopharma company active in partnering, licensing and M&A in biopharmaceuticals.

Scientific breakthrough is almost always the product of collaboration and Gilead places high value on partnering with companies and organizations whose strengths complement and augment our own.

Over the past two decades, Gilead have forged many long-term collaborations with leading academic institutions and biotechnology and pharmaceutical companies to develop innovative new therapeutics and advance the care of patients confronting life-threatening diseases.

Summary of Gilead Sciences partnering interests

Gilead Sciences partnering interests are not disclosed directly; however we can generally assume their interests are reflected in their existing pipeline and recent partnering activity.

This can be summarised as follows:

  • Liver disease
  • Cardiovascular
  • Respiratory
  • Oncology
  • Inflammation

For the latest detail on Gilead’s partnering interests, visit the business partnerships section of Gilead website > go to About Gilead > Business Partnerships for details.

Partnering outreach

Gilead Sciences are routinely present at a large number of partnering events throughout the year.

Partnering events are a great place to meet lots of potential partners face to face in a small amount of time.

Events with Gilead presence include but are not limited to:

-        BIO International Convention and Business Forum

-        BioEurope / BioEurope Spring

For a full list of forthcoming partnering events where you could meet with Gilead in person visit Current Partnering’s Event calendar.

In addition, you can find a full list of events where Gilead will be present for partnering discussions, visit the partnering section of Gilead website > go to About Gilead > Business Partnerships for details.

Contacting Gilead Sciences for partnering

Gilead Sciences can be contacting in relation to partnering through a number of channels.

Here is a list of the most common channels:

Partnering events: face to face contact is generally considered the most effective form of contact. Partnering events not only allow face to face contact but also contact with multiple companies for the price of one flight and hotel reservation. This benefit makes partnering events the most cost effective method of making personal introductions as a start point for partnering discussions.

See Current Partnering’s event calendar for details of forthcoming events.

Direct contact: there are several sources of direct contact with Gilead business development team

-        Phone: Picking up the phone and speaking with an individual is the best form of non-face to face contact as it allows your name and voice to be remembered and associated with an opportunity.

-        Email: Sending an email is another good way of making contact. Ideally, research the individual responsible for the therapy/technology area being targeted and get in touch. Gilead do not publish a list of contacts on their website, so unless you cannot find a direct contact elsewhere use the contact email here.

-        LinkedIn: Business to business contact is increasingly taking place via LinkedIn, the global online networking channel. Many of Gilead business development executives have LinkedIn profiles and can be found by viewing the company’s profile. Visit Gilead LinkedIn page

Opportunity submission form: the least favourable channel but worth using if you do not have access to the other channels mentioned above. Gilead provides an email address and postal address which can be found by partnering section of Gilead website > go to About Gilead > Business Partnerships for details.


Summary profile data for Gilead Sciences

Partnering activity for Gilead Sciences

M&A activity for Gilead Sciences


Available reports from Current Partnering

Report: Partnering Deals and Alliances with Gilead Sciences

Report: Partnering Deals and Alliances with Big Pharma


Available resources for deal coverage for Gilead

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Gilead Sciences company profile, recent partnering, M&A and financing news and articles



Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Print Friendly, PDF & Email

Leave a Reply